特定人工晶状体植入后毒性前段综合征聚集性病例报告
在共162眼植入该型号晶状体的手术眼中,7眼(4.3%)在术后1-15天出现伴纤维蛋白形成的急性前房炎症。这是首篇报告该人工晶状体相关TASS的文献。
要点
- 植入Lentis Comfort/LS-313 MF15人工晶状体后,7/162眼(4.3%)发生TASS。
- TASS表现为术后1-15天出现伴纤维蛋白形成的急性前房炎症。
- 部分病例需行纤维蛋白膜去除、YAG激光膜切开、玻璃体切除或前房冲洗。
核心结论
- 短期内在植入Lentis Comfort/LS-313 MF15人工晶状体的眼中出现TASS聚集性病例,据作者所知为首次报告该晶状体相关TASS。
主要发现
- 162眼植入Lentis Comfort/LS-313 MF15人工晶状体,其中7眼(4.3%)在顺利手术后1-15天出现伴纤维蛋白形成的急性前房炎症。
- 7眼中单纯白内障手术4眼,白内障联合微创青光眼手术3眼。
关键数值与推荐
- TASS诊断时间为术后1-15天,表现为伴纤维蛋白形成的急性前房炎症。
- 发生TASS的7眼占植入该晶状体162眼的4.3%。
临床怎么用
- 对植入Lentis Comfort/LS-313 MF15人工晶状体后出现急性前房炎症伴纤维蛋白形成的患眼,应考虑TASS可能。
- 治疗包括局部激素、纤维蛋白膜去除、YAG激光膜切开、玻璃体切除和前房冲洗。
局限性
- 回顾性病例系列,样本量小(7眼),仅报告短期聚集性病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report a cluster of cases of toxic anterior-segment syndrome (TASS) in eyes implanted with a specific foldable acrylic intraocular lens (IOL) model. DESIGN: Retrospective case series. METHODS: The medical records were reviewed for 7 eyes of 4 patients diagnosed with TASS after cataract surgery at Shimane University and Matsue Red Cross Hospital between July and November 2020. RESULTS: Among the 162 eyes implanted with the Lentis Comfort/LS-313 MF15 IOL, acute anterior chamber (AC) inflammation with fibrin formation developed 1-15 days after uneventful surgeries in 7 (4.3%) eyes (cataract surgery alone, n=4 eyes; combined cataract and minimally invasive glaucoma surgery, n=3 eyes). Other than local steroid use, fibrin membrane removal, YAG laser membranotomy, pars plana vitrectomy, and AC washout were performed to treat inflammation and/or secondary angle closure due to pupillary obstruction. CONCLUSION: We experienced a cluster of TASS cases in eyes implanted with the Lentis Comfort/LS-313 MF15 IOL in a short period of time. To our knowledge, this is the first report of TASS associated with this IOL.
引用
- Imamachi K, Sugihara K, Ikeda Y, et al. Report of a Cluster of Cases of Toxic Anterior-segment Syndrome After Implantation of a Specific Intraocular Lens Model. Am J Ophthalmol. 2021. PMID: 33826928. doi:10.1016/j.ajo.2021.03.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。